S65-19524 (1 June 1965) --- Dr. Charles A. Berry, chief of Center Medical Programs, MSC, Houston, Texas, prepares to check the blood pressure of astronaut James A. McDivitt, command pilot for the Gemini-Titan 4 spaceflight. McDivitt is on the tilt table at the Aero Medical Area, MSC, Merritt Island, where he and astronaut Edward H. White II (out of frame), GT-4 pilot, underwent preflight physicals in preparation for the four-day, 62-revolution spaceflight. The two astronauts were declared in top physical condition. In the background is Dr. Gordon Benson, NASA physician at Cape Kennedy.

S73-27707 (9 June 1973) --- Astronaut Charles Conrad Jr., Skylab 2 commander, serves as test subject for the Lower Body Negative Pressure (MO92) Experiment, as seen in this reproduction taken from a color television transmission made by a TV camera aboard the Skylab 1/2 space station cluster in Earth orbit. Scientist-astronaut Joseph P. Kerwin, Skylab 2 science pilot, assists Conrad into the LBNP device. Kerwin served as monitor for the experiment. The purpose of the MO92 experiment is to provide information concerning the time course of cardiovascular adaptation during flight, and to provide inflight data for predicting the degree of orthostatic intolerance and impairment of physical capacity to be expected upon return to Earth environment. The data collected in support of MO92 blood pressure, heart rate, body temperature, vectorcardiogram, LBNPD pressure, leg volume changes, and body weight. Photo credit: NASA

S61-02749 (5 May 1961) --- Astronaut Alan B. Shepard Jr. has his blood pressure and temperature checked prior to his Mercury-Redstone 3 (MR-3) mission, the first American manned spaceflight. The attending physician is Dr. William K. Douglas. Photo credit: NASA or National Aeronautics and Space Administration

KENNEDY SPACE CENTER, FLA. - An employee gets a blood pressure check from one of the participating organizations in Spaceport Super Safety and Health Day at KSC and Cape Canaveral Air Force Station. Many vendors and Center organizations displayed and demonstrated their products during the annual event dedicated to reinforcing safe and healthful behaviors in the workforce.

ISS026-E-015923 (7 Jan. 2011) --- NASA astronaut Catherine (Cady) Coleman, Expedition 26 flight engineer, participates in the ambulatory monitoring part of the Integrated Cardiovascular (ICV) assessment research experiment in the Kibo laboratory of the International Space Station. Coleman is wearing electrodes, a Holter Monitor 2 (HM2) for recording Electrocardiogram (ECG), a European Space Agency (ESA) Cardio pressure / Blood Pressure unit to continuously monitor blood pressure and two Actiwatches (hip/waist and ankle) for monitoring activity levels.

ISS026-E-018798 (20 Jan. 2011) --- NASA astronaut Catherine (Cady) Coleman, Expedition 26 flight engineer, is pictured in the Unity node of the International Space Station. Coleman is wearing electrodes, a Holter Monitor 2 (HM2) for recording Electrocardiogram (ECG), a European Space Agency (ESA) Cardio pressure / Blood Pressure unit to continuously monitor blood pressure and two Actiwatches (hip/waist and ankle) for monitoring activity levels.

Astronaut Weitz assists Astronaut Kerwin with blood pressure cuff. Skylab-2 mission duration 5/25/73 thru 6/22/73.

(PCG) Protein Crystal Growth Renin. Enzyme produced by the kidneys, plays a major role in the chemical reaction that controls blood pressure. Principal Investigator on STS-26 was Charles Bugg.

STS055-233-019 (26 April-6 May 1993) --- Terence T. (Tom) Henricks, STS-55 pilot, wears a special collar for a space adaptation experiment in the science module onboard the Earth-orbiting Space Shuttle Columbia. The Baroreflex (BA) experiment is designed to investigate the theory that light-headedness and a reduction in blood pressures upon standing after landing may arise because the normal reflex system regulating blood pressure behaves differently after having adapted to a microgravity environment. These space-based measurements of the baroreflex will be compared to ground measurements to determine if microgravity affects the reflex.

Horse Serum Albumin crystals grown during the USML-1 (STS-50) mission's Protein Crystal Growth Glovebox Experiment. These crystals were grown using a vapor diffusion technique at 22 degrees C. The crystals were allowed to grow for nine days while in orbit. Crystals of 1.0 mm in length were produced. The most abundant blood serum protein, regulates blood pressure and transports ions, metabolites, and therapeutic drugs. Principal Investigator was Edward Meehan.

SL3-108-1278 (July-September 1973) --- Scientist-astronaut Owen K. Garriott, science pilot of the Skylab 3 mission, lies in the Lower Body Negative Pressure Device in the work and experiments area of the Orbital Workshop (OWS) crew quarters of the Skylab space station cluster in Earth orbit. This picture was taken with a hand-held 35mm Nikon camera. Astronauts Garriott, Alan L. Bean and Jack R. Lousma remained with the Skylab space station in orbit for 59 days conducting numerous medical, scientific and technological experiments. The LBNPD (MO92) Experiment is to provide information concerning the time course of cardiovascular adaptation during flight, and to provide in-flight data for predicting the degree of orthostatic intolerance and impairment of physical capacity to be expected upon return to Earth environment. The bicycle ergometer is in the right foreground. Photo credit: NASA

S65-28710 (17 Aug. 1965) --- Astronaut L. Gordon Cooper Jr., command pilot for the Gemini-5 spaceflight, has his blood pressure checked by Dr. Charles A. Berry, chief, Center Medical Programs, Manned Spacecraft Center, during a preflight physical examination.

Using Dr. Dave E. Ward, a JSC physician, as a test subject, cosmonaut Gennadiy M. Strekalov (left), rehearses the taking of blood pressure. This is a service he will likely be performing a great deal next year when he boards Russia's Mir Space Station, in Earth-orbit, as Mir 18 flight engineer.

As the most abundant protein in the circulatory system albumin contributes 80% to colloid osmotic blood pressure. Albumin is also chiefly responsible for the maintenance of blood pH. It is located in every tissue and bodily secretion, with extracellular protein comprising 60% of total albumin. Perhaps the most outstanding property of albumin is its ability to bind reversibly to an incredible variety of ligands. It is widely accepted in the pharmaceutical industry that the overall distribution, metabolism, and efficiency of many drugs are rendered ineffective because of their unusually high affinity for this abundant protein. An understanding of the chemistry of the various classes of pharmaceutical interactions with albumin can suggest new approaches to drug therapy and design. Principal Investigator: Dan Carter/New Century Pharmaceuticals

This is a wide-angle view of the Orbital Workshop lower level experiment area. In center foreground is the ergometer bicycle. In center background is a litter chair for the Human Vestibular Function experiment (Skylab Experiment M131) and in right background is the Lower Body Negative Pressure System experiment (Skylab Experiment M092). The ergometer bicycle was used for metabolic activity experiments and exercise. The purpose of the Human Vestibular (irner ear) Function experiment was to examine the effect of weightlessness on man's sensitivity and susceptibility to motion rotation, and his perception of orientation. The Lower Body Negative Pressure experiment investigated the relationship between the zero gravity environment and cardiovascular deconditioning. A characteristic of cardiovascular deconditoning is the partial failure of the blood vessels resulting in the excessive pooling of the blood in the legs when a person assumes an erect posture in a gravity field. The Marshall Space Flight Center had the program management responsibility for the development of Skylab hardware and experiments.

ISS035-E-022356 (17 April 2013) --- In support of the Blood Pressure Regulation Experiment (BP Reg), Expedition 35 Commander Chris Hadfield of the Canadian Space Agency is pictured after having set up the Human Research Facility (HRF) PFS (Pulmonary Function System) and the European Physiology Module (EPM) Cardiolab (CDL) Leg/Arm Cuff System (LACS) and conducting the first ever session of this experiment. The test, which will be repeated using other crew members as well, will help to identify the astronauts who could benefit from countermeasures before returning to Earth. Thus, this method has great potential for astronaut health monitoring during future long-term space flights and it also has important implications for testing of individuals on Earth, especially the elderly, who are at risk for fainting. The research will also allow demonstrating the feasibility of obtaining a set of indicators of overall cardiovascular regulation from the non-invasive measurement of continuous blood pressure.

ISS035-E-022360 (17 April 2013) --- In support of the Blood Pressure Regulation Experiment (BP Reg), Expedition 35 Commander Chris Hadfield of the Canadian Space Agency is pictured after having set up the Human Research Facility (HRF) PFS (Pulmonary Function System) and the European Physiology Module (EPM) Cardiolab (CDL) Leg/Arm Cuff System (LACS) and conducting the first ever session of this experiment. The test, which will be repeated using other crew members as well, will help to identify the astronauts who could benefit from countermeasures before returning to Earth. Thus, this method has great potential for astronaut health monitoring during future long-term space flights and it also has important implications for testing of individuals on Earth, especially the elderly, who are at risk for fainting. The research will also allow demonstrating the feasibility of obtaining a set of indicators of overall cardiovascular regulation from the non-invasive measurement of continuous blood pressure.

ISS035-E-022357 (17 April 2013) --- In support of the Blood Pressure Regulation Experiment (BP Reg), Expedition 35 Commander Chris Hadfield of the Canadian Space Agency is pictured after having set up the Human Research Facility (HRF) PFS (Pulmonary Function System) and the European Physiology Module (EPM) Cardiolab (CDL) Leg/Arm Cuff System (LACS) and conducting the first ever session of this experiment. The test, which will be repeated using other crew members as well, will help to identify the astronauts who could benefit from countermeasures before returning to Earth. Thus, this method has great potential for astronaut health monitoring during future long-term space flights and it also has important implications for testing of individuals on Earth, especially the elderly, who are at risk for fainting. The research will also allow demonstrating the feasibility of obtaining a set of indicators of overall cardiovascular regulation from the non-invasive measurement of continuous blood pressure.

This 1970 photograph shows Skylab's In-Flight Lower Body Negative Pressure experiment facility, a medical evaluation designed to monitor changes in astronauts' cardiovascular systems during long-duration space missions. This experiment collected in-flight data for predicting the impairment of physical capacity and the degree of orthostatic intolerance to be expected upon return to Earth. Data to be collected were blood pressure, heart rate, body temperature, vectorcardiogram, lower body negative pressure, leg volume changes, and body mass. The Marshall Space Flight Center had program management responsibility for the development of Skylab hardware and experiments.

This chart details Skylab's In-Flight Lower Body Negative Pressure experiment facility, a medical evaluation designed to monitor changes in astronauts' cardiovascular systems during long-duration space missions. This experiment collected in-flight data for predicting the impairment of physical capacity and the degree of orthostatic intolerance to be expected upon return to Earth. Data to be collected were blood pressure, heart rate, body temperature, vectorcardiogram, lower body negative pressure, leg volume changes, and body mass. The Marshall Space Flight Center had program management responsibility for the development of Skylab hardware and experiments.

S73-34180 (7 Aug. 1973) --- A medium close-up view of astronaut Jack R. Lousma, Skylab 3 pilot, in the Lower Body Negative Pressure Device (LBNPD), as astronaut Alan L. Bean, commander, works around the leg band area. This portion of the LBNPD MO-92 experiment was televised on Aug. 7, 1973. The LBNPD experiment is to provide information concerning the time course of cardiovascular adaptation during flight, and to provide in-flight data for predicting the degree of orthostatic intolerence and impairment of physical capacity to be expected upon returning to Earth environment. The bicycle ergometer is in the background, partially visible behind Bean. Photo credit: NASA

STS040-30-008 (5-14 June 1991) --- Astronaut Tamara E. Jernigan, after applying a blood pressure cuff to an experiment, watches it in operation. The experiment is the intravenous infusion pump. The device is being considered for use on Space Station Freedom's Health Maintenance Facility. Dr. Jernigan is one of seven crew members supporting the nine-day Spacelab Life Sciences (SLS-1) mission aboard the Earth-orbiting Space Shuttle Columbia.

ISS042E236075 (02/10/2015) --- Astronauts in space must exercise regularly to keep muscles from deteriorating. The busy schedule aboard the International Space Station has these regular periods worked in as NASA astronaut Terry Virts shows in this Tweet he sent out on Feb. 10, 2015 with the comment: "Periodic Fitness Evaluation- riding the bike with a heart rate monitor, EKG, and blood pressure machine hooked up".

ISS009-E-13739 (5 July 2004) --- Cosmonaut Gennady I. Padalka, Expedition 9 commander representing Russia’s Federal Space Agency, works with the Cardiocog experiment in the Zvezda Service Module of the International Space Station (ISS). Originally part of Pedro Duque's VC5 "Cervantes" science program, Cardiocog studies changes in the human cardiovascular system in micro-G, expressed in the peripheral arteries, and the vegetative regulation of arterial blood pressure and heart rate.

Cosmonaut Vladimir N. Dezhurov (center), Mir 18 mission commander, gets his blood pressure taken by Dr. Michael J. Barrett, flight surgeon. Cosmonaut Anatoliy Y. Solovyev (right), Mir 19 mission commander, looks on. Solovyev, Dezhurov, along with their respective flight engineers and a number of other cosmonauts and astronauts participating in the joint program, were in Houston, Texas, to prepare for their upcoming missions.

S85-26571 (Feb 1985) --- Wearing a special collar, Millie Hughes-Fulford, payload specialist, practices medical test operations scheduled for the Spacelab Life Sciences (SLS-1) mission. Robert Ward Phillips, backup payload specialist, looks on. The collar, called the baroflex neck pressure chamber, is designed to stimulate the bioceptors in the carotid artery, one of the two main arteries that supply blood to the head.

STS008-13-0361 (30 Aug.-5 Sept. 1983) --- Astronaut Guion S. Bluford, STS-8 mission specialist, assists Dr. William E. Thornton (out of frame) with a medical test that requires use of the treadmill exercising device designed for spaceflight by the STS-8 medical doctor. This frame was shot with a 35mm camera. Photo credit: NASA

S61-02740 (5 May 1961) --- Astronaut Alan B. Shepard Jr. has his heart rate checked prior to his Mercury-Redstone 3 (MR-3) mission, the first American manned suborbital spaceflight. The attending physician is Dr. William K. Douglas. Photo credit: NASA or National Aeronautics and Space Administration

ISS043E091755 (04/07/2015) --- Expedition 43 Commander Terry Virts is seen here working inside of the Columbus laboratory on the Blood Pressure Regulation (BP Reg) experiment. Astronauts returning from long-duration space flights risk experiencing dizziness or fainting when they stand immediately after returning to Earth. This has an important health risk as it reduces the potential for astronauts to safely escape from an emergency situation. BP Reg will help researchers develop appropriate countermeasures so that astronauts returning from long-duration space flights will have very low risk of experiencing dizziness or fainting when they return to Earth.

ISS043E091740 (04/07/2015) --- Expedition 43 Commander Terry Virts is seen here working inside of the Columbus laboratory on the Blood Pressure Regulation (BP Reg) experiment. Astronauts returning from long-duration space flights risk experiencing dizziness or fainting when they stand immediately after returning to Earth. This has an important health risk as it reduces the potential for astronauts to safely escape from an emergency situation. BP Reg will help researchers develop appropriate countermeasures so that astronauts returning from long-duration space flights will have very low risk of experiencing dizziness or fainting when they return to Earth.

This Skylab-3 onboard photograph shows Astronaut Allen Bean on the ergometer, breathing into the metabolic analyzer. Skylab's Metabolic Activity experiment (M171), a medical evaluation facility, was designed to measure astronauts' metabolic changes while on long-term space missions. The experiment obtained information on astronauts' physiological capabilities and limitations and provided data useful in the design of future spacecraft and work programs. Physiological responses to physical activity was deduced by analyzing inhaled and exhaled air, pulse rate, blood pressure, and other selected variables of the crew while they performed controlled amounts of physical work with a bicycle ergometer.

This chart details Skylab's Metabolic Activity experiment (M171), a medical evaluation facility designed to measure astronauts' metabolic changes while on long-term space missions. The experiment obtained information on astronauts' physiological capabilities and limitations and provided data useful in the design of future spacecraft and work programs. Physiological responses to physical activity was deduced by analyzing inhaled and exhaled air, pulse rate, blood pressure, and other selected variables of the crew while they performed controlled amounts of physical work with a bicycle ergometer. The Marshall Space Flight Center had program responsibility for the development of Skylab hardware and experiments.

ISS047e134605 (05/30/2016) --- ESA (European Space Agency) astronaut Tim Peake uses hardware for the Vascular Echo experiment. As humans get older on Earth, arteries stiffen and this causes an increase in blood pressure (hypertension) and elevates the risk for cardiovascular disease. Recently, it has been observed that some crew members returning from the International Space Station (ISS) have much stiffer arteries than when they went into space. The results from studying these changes could provide insight into potential countermeasures to help maintain crew member health, and quality of life for everyone.

In this International Space Station (ISS) onboard photo, Expedition Six Science Officer Donald R. Pettit works to set up the Pulmonary Function in Flight (PuFF) experiment hardware in the Destiny Laboratory. Expedition Six is the fourth and final crew to perform the PuFF experiment. The PuFF experiment was developed to better understand what effects long term exposure to microgravity may have on the lungs. The focus is on measuring changes in the everness of gas exchange in the lungs, and on detecting changes in respiratory muscle strength. It allows astronauts to measure blood flow through the lungs, the ability of the lung to take up oxygen, and lung volumes. Each PuFF session includes five lung function tests, which involve breathing only cabin air. For each planned extravehicular (EVA) activity, a crew member performs a PuFF test within one week prior to the EVA. Following the EVA, those crew members perform another test to document the effect of exposure of the lungs to the low-pressure environment of the space suits. This experiment utilizes the Gas Analyzer System for Metabolic Analysis Physiology, or GASMAP, located in the Human Research Facility (HRF), along with a variety of other Puff equipment including a manual breathing valve, flow meter, pressure-flow module, pressure and volume calibration syringes, and disposable mouth pieces.

ISS013-E-54170 (July 2006) --- European Space Agency (ESA) astronaut Thomas Reiter, Expedition 13 flight engineer, looks over a procedures checklist in the Zvezda Service Module of the International Space Station.

Astronaut Chiaki Mukai conducts the Lower Body Negative Pressure (LBNP) experiment inside the International Microgravity Laboratory-2 (IML-2) mission science module. Dr. Chiaki Mukai is one of the National Space Development Agency of Japan (NASDA) astronauts chosen by NASA as a payload specialist (PS). She was the second NASDA PS who flew aboard the Space Shuttle, and was the first female astronaut in Asia. When humans go into space, the lack of gravity causes many changes in the body. One change is that fluids normally kept in the lower body by gravity shift upward to the head and chest. This is why astronauts' faces appear chubby or puffy. The change in fluid volume also affects the heart. The reduced fluid volume means that there is less blood to circulate through the body. Crewmembers may experience reduced blood flow to the brain when returning to Earth. This leads to fainting or near-fainting episodes. With the use of the LBNP to simulate the pull of gravity in conjunction with fluids, salt tablets can recondition the cardiovascular system. This treatment, called "soak," is effective up to 24 hours. The LBNP uses a three-layer collapsible cylinder that seals around the crewmember's waist which simulates the effects of gravity and helps pull fluids into the lower body. The data collected will be analyzed to determine physiological changes in the crewmembers and effectiveness of the treatment. The IML-2 was the second in a series of Spacelab flights designed by the international science community to conduct research in a microgravity environment Managed by the Marshall Space Flight Center, the IML-2 was launched on July 8, 1994 aboard the STS-65 Space Shuttle Orbiter Columbia mission.

The first United States Microgravity Laboratory (USML-1) flew in orbit inside the Spacelab science module for extended periods, providing scientists and researchers greater opportunities for research in materials science, fluid dynamics, biotechnology (crystal growth), and combustion science. In this photograph, Astronaut Bornie Dunbar and Astronaut Larry DeLucas are conducting the Lower Body Negative Pressure (LBNP) experiment, which is to protect the health and safety of the crew and to shorten the time required to readapt to gravity when they return to Earth. When humans go into space, the lack of gravity causes many changes in the body. One change is that fluids normally kept in the lower body by gravity, shift upward to the head and chest. This is why astronauts' faces appear chubby or puffy. The change in fluid volume also affects the heart. The reduced fluid volume means that there is less blood to circulate through the body. Crewmembers may experience reduced blood flow to the brain when returning to Earth. This leads to fainting or near-fainting episodes. With the use of LBNP to simulate the pull of gravity in conjunction with fluids, salt tablets can recondition the cardiovascular system. This treatment, called "soak," is effective up to 24 hours. The LBNP uses a three-layer collapsible cylinder that seals around the crewmember's waist which simulates the effects of gravity and helps pull fluids into the lower body. The data collected will be analyzed to determine physiological changes in the crewmembers and effectiveness of the treatment. The USML-1 was launched aboard the Space Shuttle Orbiter Columbia (STS-50) on June 25, 1992.